In-depth Research Report of Global Biosimilars Market (2019 Version)


Report ID : RC-8440 Category : Pharmaceuticals
Published Date : 15-Feb-19 Pages : 135 Format : PDF
The Report mainly includes sales, revenue, trade, competition, investment, forecast and marketing of the product and the segments here include companies, types, applications, regions, countries, etc. 

The Global  market of Biosimilars is expected to grow at a CAGR of roughly  over the next five years, will reach  million US$ in 2023, from  million US$ in 2017, according to a new LDI (Lilan Data & Info) study.

The regions of Biosimilars contain all Global  market, especially in North America, Europe, Asia Pacific, Latin America and MEA. 

Players include Sandoz International, Hospira, Teva Pharmaceutical, Dr. Reddy's Laboratories, Biocon, Mylan, Amgen, Celltrion, Roche Diagnostics, Merck KGaA, etc.

Types cover Injection, Tablets, Others, etc. and applications cover Ankylosing Spondylitis, Tumor, Rheumatoid Arthrtis, Cardiovascular, etc.

There are 11 Chapters to deeply display the global Biosimilars market.
Chapter 1, is  definition and segment of Biosimilars;
Chapter 2, is executive summary of Biosimilars Market;
Chapter 3, to explain the industry chain of Biosimilars;
Chapter 4, to show info and data comparison of  Biosimilars Players;
Chapter 5, to show comparison of types;
Chapter 6, to show comparison of applications;
Chapter 7, to show comparison of regions and coutries(or sub-regions);
Chapter 8, to show competition and trade situation of Biosimilars Market;
Chapter 9, to forecast Biosimilars market in the next years;
Chapter 10, to show investment of Biosimilars Market;
Table of Contents

Chap. 1, Definition and Segment
    1.1, Definition
    1.2, Segments
        A, Type Segment
        B, Application Segment
        C, Regional Segment

Chap. 2, Executive Summary of Biosimilars Market

Chap. 3, Industrial Chain Analysis of Biosimilars Market
    3.1, Industrial Chain of Biosimilars
    3.2, Production Process of Biosimilars
    3.3, Upstream and Cost of Biosimilars
        A, Raw Materials Cost
        B, Equipment Market
        C, Labor Cost Analysis
        D, Cost Structure Analysis
    3.4, Distribution
        A, Marketing Channel
        B, Distributors/Agents
    3.5, Downstream

Chap. 4, Comparison of Companies
    4.1, Comprehensive Analysis of Biosimilars Companies
        4.1.1, Business Comparison of Companies
        4.1.2, Biosimilars Business Distribution by Companies
        4.1.3, Biosimilars Product Comparison by Companies
    4.2, Biosimilars Sales and Revenue by Companies
    4.3, Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) Analysis of Biosimilars by Companies
        Comp. 1: Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) of Sandoz International
        Comp. 2: Data Details of Hospira
        Comp. 3: Data Details of Teva Pharmaceutical
        Comp. 4: Data Details of Dr. Reddy's Laboratories
        Comp. 5: Data Details of Biocon
        Comp. 6: Data Details of Mylan
        Comp. 7: Data Details of Amgen
        Comp. 8: Data Details of Celltrion
        Comp. 9: Data Details of Roche Diagnostics
        Comp. 10: Data Details of Merck KGaA

Chap. 5, Comparison of Types (Sales, Revenue, Share, Price, Growth)
    5.1, Injection
    5.2, Tablets
    5.3, Others

Chap. 6, Comparison of Applications (Sales, Share, Growth)
    6.1, Ankylosing Spondylitis
    6.2, Tumor
    6.3, Rheumatoid Arthrtis
    6.4, Cardiovascular

Chap. 7, Comparison of Regions (Sales, Price, Revenue, Share, Growth)
    7.1, North America
        7.1.1, Sub-regions of North America
        7.1.2, U.S.A.
        7.1.3, Canada
    7.2, Europe
        7.2.1 Sub-regions of Europe
        7.2.2, Germany
        7.2.3, U.K.
        7.2.4, France
        7.2.5, Italy
        7.2.6, Spain
    7.3, Asia Pacific
        7.3.1, Sub-regions of Asia Pacific
        7.3.2, China
        7.3.3, India
        7.3.4, Japan
        7.3.5, Oceania
        7.3.6, SEA
    7.4, Latin America
        7.4.1, Sub-regions of Latin America
        7.4.2, Brazil
        7.4.3, Mexico
    7.5, MEA
        7.5.1, Sub-regions of MEA
        7.5.2, Mid-east
        7.5.3, South Africa

Chap. 8, Competition and Trade Situation Analysis of Biosimilars Market
    8.1, Competition Situation by Players
        8.1.1, Market Concentration by Players
        8.1.2, Mergers & Acquisitions, Expansions
        8.1.3, New Entrants
    8.2, Competition Situation by Regions
    8.3, Trade Situation by Regions
        8.3.1, Trade Data (Import and Export) of North America
        8.3.2, Trade Data of Europe
        8.3.3, Trade Data of Asia Pacific
        8.3.4, Trade Data of Latin America
        8.3.5, Trade Data of MEA

Chap. 9, Forecast of Biosimilars Market
    9.1, Market Size Forecast
        9.1.1, Opportunity
        9.1.2, Restraints
        9.1.3, Market Trend (Sales, Revenue)
    9.2, Types Forecast (Sales, Revenue)
    9.3, Application Forecast (Sales)
    9.4, Regional Forecast (Sales, Revenue)

Chap. 10, Investment Analysis of Biosimilars Market
    10.1, Investment Opportunity
    10.2, Investment Calculation
        10.2.1, Cost Calculation
        10.2.2, Revenue Calculation
        10.2.3, Economic Performance Evaluation

Chap. 11, Appendix (Free Info)
    11.1, Profiles and Biosimilars Product Information of Key Companies
        Comp. 1: (Profiles and Biosimilars Product Information of) Sandoz International
        Comp. 2: Hospira
        Comp. 3: Teva Pharmaceutical
        Comp. 4: Dr. Reddy's Laboratories
        Comp. 5: Biocon
        Comp. 6: Mylan
        Comp. 7: Amgen
        Comp. 8: Celltrion
        Comp. 9: Roche Diagnostics
        Comp. 10: Merck KGaA
    11.2, Contact Info of Related Companies
    11.3, Assumptions and Research Methodology
    11.4, Average Annual Exchange Rate
    11.5, Global and Regional Economic Change
    11.6, Global and Regional Labor Cost Index
    11.7, Relevant Policy (Examples)
    11.8, Relevant Patent and Technological Innovation (Examples)
    11.9, Info & Data Source
    11.10, Details of Abbreviated Words
    11.11, Disclaimer
    11.12, Author List

Sidebar Menu